Case Study: Outsourcing Medical Monitoring for antipsychotic medication

The Challenge
Clozapine is an antipsychotic medication used in treatment-resistant schizophrenia and psychosis in Parkinson’s Disease. Treatment with clozapine comes with a risk of agranulocytosis.
Since the introduction by the MHRA for white blood cell count monitoring in clozapine patients, the incidence of those developing agranulocytosis has decreased markedly.
When a clozapine monitoring service is not used, evidence suggests a mortality rate from agranulocytosis of 0.3% (compared to 0.01% when clozapine is used in conjunction with a monitoring service.
Key requirements for the client
It is a regulatory requirement that blood monitoring should be carried out in clozapine patients in alignment with specific official recommendations, including daily blood monitoring in patients that fall below a certain threshold.
Given the frequency of testing of clozapine patients, the often urgent need to access support for the service, and the complexity of the testing protocols, the client was in need of robust and high quality Out of Hours support solution.